Great Bay Bio
Provides technical services concerning CMC and AI biologics and develops biomedical products.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
* | N/A | Series B | |
| Total Funding | 000k | ||
Related Content
Great Bay Bio is a biotechnology company specializing in bioprocessing solutions that accelerate drug development. The company leverages artificial intelligence (AI) to enhance the efficiency and effectiveness of bioprocessing, which is the use of living cells or their components to obtain desired products. Great Bay Bio serves pharmaceutical companies and research institutions, providing them with cutting-edge tools to streamline the development of biologics, which are drugs derived from living organisms. Operating in the biopharmaceutical market, the company employs a business model that includes both service-based and product-based revenue streams. It makes money by offering technical services and selling proprietary bioprocessing products.
Keywords: biotechnology, bioprocessing, AI-driven, drug development, pharmaceutical, biologics, efficiency, research institutions, technical services, proprietary products.